|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.46 EUR | +0.30% |
|
+2.47% | -7.70% |
| 03:21pm | SANOFI : UBS reiterates its Neutral rating | ZD |
| 01:19pm | EXECUTIVE CHANGES: Rank Group confirms interim CEO Harris as permanent | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 105B | |||||
| 1,060B | |||||
| 619B | |||||
| 438B | |||||
| 333B | |||||
| 282B |
- Stock Market
- Stocks
- SAN Stock
- Charts Sanofi
- Sector Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
